US Stock MarketDetailed Quotes
DMAC DiaMedica Therapeutics
- 5.655
- +0.445+8.54%
Close Nov 29 13:00 ET
- 5.655
- 0.0000.00%
Post 13:02 ET
241.81MMarket Cap-10098P/E (TTM)
5.660High5.210Low86.84KVolume5.260Open5.210Pre Close479.04KTurnover0.33%Turnover RatioLossP/E (Static)42.76MShares5.66052wk High5.04P/B148.60MFloat Cap2.14052wk Low--Dividend TTM26.28MShs Float10.880Historical High--Div YieldTTM8.64%Amplitude1.120Historical Low5.516Avg Price1Lot Size
DiaMedica Therapeutics Key Stats
EPS
According to the latest financial report of DiaMedica Therapeutics, the latest earnings per share (TTM) for the company is -0.15. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about DiaMedica Therapeutics's free cash flow? The latest report shows it as -4.48M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of DiaMedica Therapeutics shows that the company's current ratio is 11.81, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of DiaMedica Therapeutics, the quick ratio is 11.75, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of DiaMedica Therapeutics? The latest ROE figure is -12.38%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of DiaMedica Therapeutics, the total asset return on investment (ROA) is -11.48%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check DiaMedica Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of DiaMedica Therapeutics, the net profit margin is -277.40%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data